Family Pharmacy of Statesville – FDA 483, Feb 12, 2020
Family Pharmacy of Statesville was inspected and cited for multiple deficiencies in both sterile and non-sterile drug production. Key issues include inadequate aseptic processing controls, lack of endotoxin testing for intrathecal products, facility design flaws, and insufficient quality control for water and equipment calibration. These observations indicate significant concerns regarding the sterility assurance and overall quality of drug products manufactured at the facility.
ID · bf9e8a91-fd05-47cb-b5c3-5783964cae5d
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.